Gemcitabine-Induced Acute Coronary Syndrome: A Case Report

被引:9
作者
Ozturk, Banu [1 ]
Tacoy, Gulten [2 ]
Coskun, Ugur [1 ]
Yaman, Emel [1 ]
Sahin, Giray [1 ]
Buyukberber, Suleyman [1 ]
Yildiz, Ramazan [1 ]
Kaya, Ali O. [1 ]
Topal, Salih [2 ]
Ozdemir, Murat [2 ]
Benekli, Mustafa [1 ]
机构
[1] Gazi Univ, Sch Med, Dept Med Oncol, TR-06500 Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Cardiol, TR-06500 Ankara, Turkey
关键词
Gemcitabine; Coronary syndrome; Left bundle-branch block; ACUTE MYOCARDIAL-INFARCTION; PHASE-II; 5-FLUOROURACIL; THERAPY; CANCER;
D O I
10.1159/000163051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To report a case of metastatic leiomyosarcoma, in which a patient developed chest pain accompanied by acute left bundle-branch block (LBBB) after gemcitabine infusion. Clinical Presentation and Intervention: A 59-year-old woman admitted with bilateral pulmonary nodules had classic risk factors for coronary heart disease and coronary stenosis as demonstrated by previous coronary angiography. She was treated with gemcitabine infusion, and 30 min later she experienced severe chest pain accompanied by acute LBBB confirmed by ECG. We suspected gemcitabine-induced coronary vasospasm exacerbated by the preexisting coronary artery disease as the cause of the acute coronary syndrome. The patient was subsequently treated with antianginal therapy and percutaneous coronary intervention. Her chest pain resolved and LBBB disappeared. She was discharged 2 days later without any further cardiac events. No additional cancer therapy was given and she died 5 months later, due to disease progression. Conclusion: This case showed that chemotherapeutic agents must be administered with intensive cardiac monitoring especially in patients with cardiac disease and well-known risk factors to prevent the development of cardiac complications, despite an agent not being known to be 'cardiotoxic'. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [21] Gemcitabine-induced systemic capillary leak syndrome
    De Pas, T
    Curigliano, G
    Franceschelli, L
    Catania, C
    Spaggiari, L
    de Braud, F
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1651 - 1652
  • [22] Gemcitabine-induced haemolytic uremic syndrome,although infrequent,can it be prevented:A case report and review of literature
    Esther U Cidon
    Pilar A Martinez
    Tamas Hickish
    World Journal of Clinical Cases, 2018, (12) : 531 - 537
  • [23] Gemcitabine-induced thrombotic microangiopathy
    Richmond, J.
    Gilbar, P.
    Abro, E.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (11) : 1240 - 1242
  • [24] Drug-Eluting Stents: Their Preventative/Prophylactic Role Against Gemcitabine Induced Acute Coronary Syndrome
    Hamdan, Jaafar A.
    Youssef, Kerolos N.
    Khan, Aafreen
    Abdalla, Mohammed A.
    Zakhary, Christine M.
    Rushdi, Hiam
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [25] Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
    Lopez Rubio, Maria Esperanza
    Rodado Martinez, Raquel
    Luisa Illescas, Maria
    Mateo Bosch, Encarnacion
    Martinez Diaz, Mercedes
    de la Vara Inesta, Lourdes
    Cabezuelo, Basilio
    Morales Albuja, Maria Elisa
    Lucas Guillen, Eladio
    Jimeno Garcia, Luisa
    CLINICAL NEPHROLOGY, 2017, 87 (02) : 100 - 106
  • [26] Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review
    Ritchie, Georgia E.
    Fernando, Mangalee
    Goldstein, David
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 1 - 7
  • [27] An unusual case of gemcitabine-induced radiation recall
    Squire, Sarah
    Chan, Michael
    Feller, Edward
    Mega, Anthony
    Gold, Richard
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (06): : 636 - 636
  • [28] Intravesically instilled gemcitabine-induced lung injury in a patient with invasive urothelial carcinoma: A case report
    Zhou, Xiao-Ming
    Wu, Cen
    Gu, Xiu
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (19) : 4652 - 4659
  • [29] Gemcitabine-Induced Myositis in a Luminal B Breast Cancer patient: A Case Report
    Badran, Ahmed
    Ali, Saad Salman
    Arabi, Tarek Ziad
    Hinkston, Abdullaah Khaleel
    Shaik, Abdullah
    Elshenawy, Mahmoud A.
    Ajarim, Dahish
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2023, 16
  • [30] Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: A case report
    Facchini L.
    Lucchesi M.
    Stival A.
    Roperto R.M.
    Melosi F.
    Materassi M.
    Farina S.
    Tintori V.
    De Martino M.
    Sardi I.
    Journal of Medical Case Reports, 11 (1)